| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...857682H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0057682 |
| P932 | PMC publication ID | 3584045 |
| P698 | PubMed publication ID | 23460893 |
| P5875 | ResearchGate publication ID | 235788097 |
| P50 | author | Jin-Chung Chen | Q41843136 |
| Ya-Tin Lin | Q59693441 | ||
| Hao-Li Liu | Q87680631 | ||
| P2093 | author name string | Chao-Lin Liu | |
| Chia-Rui Shen | |||
| Tzu-Chen Yen | |||
| Chih-Jen Wen | |||
| Kuo-Chen Wei | |||
| Chiung-Yin Huang | |||
| Po-Hung Hsu | |||
| P2860 | cites work | Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions | Q24531466 |
| Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications | Q28297458 | ||
| AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial | Q28307713 | ||
| Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound | Q30447740 | ||
| Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment | Q30474002 | ||
| Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients | Q30477383 | ||
| Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain | Q30479578 | ||
| Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q30500905 | ||
| Adeno-associated virus serotypes: vector toolkit for human gene therapy | Q33249130 | ||
| Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. | Q33713108 | ||
| Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons | Q33713769 | ||
| Safety and tolerability of putaminal AADC gene therapy for Parkinson disease | Q33731687 | ||
| Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits | Q33954300 | ||
| Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound | Q33992793 | ||
| Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 | ||
| Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta | Q34158558 | ||
| RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy | Q34166253 | ||
| Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice | Q34429058 | ||
| Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery | Q34564681 | ||
| Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial | Q34640765 | ||
| Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. | Q34778098 | ||
| Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates | Q35086714 | ||
| Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
| Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo | Q35948485 | ||
| Pseudotyped adeno-associated virus 2/9-delivered CCL11 shRNA alleviates lung inflammation in an allergen-sensitized mouse model | Q36401352 | ||
| Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina | Q36439639 | ||
| Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. | Q36541150 | ||
| Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity | Q36631977 | ||
| Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges | Q37866086 | ||
| Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines | Q39546264 | ||
| Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states | Q39996419 | ||
| Safety study and characterization of E1A-liposome complex gene-delivery protocol in an ovarian cancer model | Q40825865 | ||
| Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach | Q40870377 | ||
| Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus | Q41052074 | ||
| Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain | Q41333437 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma | Q42797865 | ||
| Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment | Q43088262 | ||
| Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle | Q44474527 | ||
| Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
| Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
| CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease. | Q45376997 | ||
| Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus | Q45712572 | ||
| Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus | Q45743733 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging. | Q47875953 | ||
| Immune responses to AAV in a phase I study for Canavan disease | Q48620414 | ||
| Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q50245668 | ||
| Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles | Q50250294 | ||
| Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. | Q50761827 | ||
| Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle. | Q54457954 | ||
| Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation | Q54888139 | ||
| Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors | Q74285552 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| microbubble | Q6839290 | ||
| focused ultrasound | Q50333304 | ||
| P304 | page(s) | e57682 | |
| P577 | publication date | 2013-02-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound | |
| P478 | volume | 8 |
| Q30448815 | A novel cationic microbubble coated with stearic acid-modified polyethylenimine to enhance DNA loading and gene delivery by ultrasound |
| Q30368351 | Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening |
| Q59968531 | Acoustically targeted chemogenetics for the non-invasive control of neural circuits |
| Q51185898 | Antibody-coated nanoparticles are promising molecular probes for microscopic analysis of cell behavior. |
| Q58600222 | Applications of Focused Ultrasound in Cerebrovascular Diseases and Brain Tumors |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q39013294 | Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain |
| Q28080611 | Drug and gene delivery across the blood-brain barrier with focused ultrasound |
| Q30414698 | Drug delivery across the blood-brain barrier using focused ultrasound |
| Q30387126 | Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo. |
| Q28082016 | Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. |
| Q30394357 | Focused ultrasound-mediated drug delivery through the blood-brain barrier |
| Q38306886 | Gene delivery in tissue engineering and regenerative medicine. |
| Q57020987 | In vivo methods for acute modulation of gene expression in the central nervous system |
| Q97599625 | Innovations in the Neurosurgical Management of Epilepsy |
| Q104516383 | Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders |
| Q30434125 | Investigation of temporal vascular effects induced by focused ultrasound treatment with speckle-variance optical coherence tomography |
| Q88467192 | Low-intensity ultrasound promotes the horizontal transfer of resistance genes mediated by plasmids in E. coli |
| Q28817563 | MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound |
| Q90210921 | MRI Monitoring and Quantification of Ultrasound-Mediated Delivery of Liposomes Dually Labeled with Gadolinium and Fluorophore through the Blood-Brain Barrier |
| Q91733486 | MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain |
| Q60923907 | Magnetic Resonance-Guided Focused Ultrasound : Current Status and Future Perspectives in Thermal Ablation and Blood-Brain Barrier Opening |
| Q30367059 | Microbubble gas volume: A unifying dose parameter in blood-brain barrier opening by focused ultrasound |
| Q38612543 | Microbubble-Assisted Ultrasound for Drug Delivery in the Brain and Central Nervous System |
| Q30435931 | Microbubble-mediated ultrasound enhances the lethal effect of gentamicin on planktonic Escherichia coli |
| Q58572994 | Modulation of Brain Function and Behavior by Focused Ultrasound |
| Q27026978 | Nanoscale drug delivery systems and the blood-brain barrier |
| Q30374364 | Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening |
| Q100415690 | Non-invasive molecularly-specific millimeter-resolution manipulation of brain circuits by ultrasound-mediated aggregation and uncaging of drug carriers |
| Q31048620 | Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound |
| Q27301281 | Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease. |
| Q30394725 | Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus |
| Q28080896 | Optogenetic tools for modulating and probing the epileptic network |
| Q58796703 | State-of-the-art of microbubble-assisted blood-brain barrier disruption |
| Q31114235 | Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery |
| Q30407897 | The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure |
| Q64241244 | Theranostic Strategy of Focused Ultrasound Induced Blood-Brain Barrier Opening for CNS Disease Treatment |
| Q52568379 | Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease. |
| Q28539271 | Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system |
Search more.